$1.35 expected Revenue: $20.38 billion versus $20.59 billion expected Net income rose 47% to $5.1 billion, or $1.43 per share, from $3.45 billion, or 86 cents per share, a year ago
We show the utmost appreciation for Judy Magnum CCRC, CRA and Rita Silverman MPS for assisting with the coordination of the study from the clinical research office
Our team of experienced therapists and addiction professionals is equipped to treat a wide variety of substance use disorders, including: Beyond clinical treatment, we emphasize rebuilding personal confidence and restoring meaningful connections
While that's substantially higher than the 600mg starting dose we generally favor for people new to NAC, it reflects the GlyNAC protocols studied in healthy-aging research.34 57 58 Some readers may prefer to start with a smaller serving for tolerability, but the clinical research on GlyNAC has generally evaluated gram-level doses of both ingredients, so it's unclear whether substantially lower amounts would provide the same benefits